COVID-19 vaccine study for older adults and those at risk
Part of Infections, Lungs & breathing clinical trials.
This study tests an updated mRNA COVID-19 vaccine to see how well it boosts immunity and how safe it is. It may help protect you from severe COVID-19 if you are older or have certain health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older, or you are 12 to 64 years old with at least one condition that increases your risk of severe COVID-19.
- You have not had a COVID-19 infection in the last 6 months.
- You have not had a COVID-19 vaccine in the last 6 months.
- You are not currently ill or feverish (within 72 hours before the first visit).
- You have not taken immunosuppressive medications or received certain blood products in the last 90 days.
- If you are a woman able to have children, you must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This study tests a new mRNA vaccine (called mRNA-1283) to protect against COVID-19 in children from 6 months to under 12 years old. It aims to see if the vaccine is safe and produces a good immune response.
This study tests two different ways of giving the covid-19 vaccine to see which one works better. It may help improve how vaccines are delivered in the future.
This trial tests an updated COVID-19 booster vaccine designed to improve protection for people who are older or have health conditions that increase their risk of severe COVID-19. If you qualify, you would receive one dose of the study vaccine and be monitored for safety and immune response.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This study tests a new booster vaccine against COVID-19 that uses mRNA technology, similar to the Pfizer or Moderna shots. If you've already had your primary series and a booster, this could help keep your immunity strong.
Hear when a new SARS CoV-2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.